Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
JAMA ; 291(16): 1994-8, 2004 Apr 28.
Article in English | MEDLINE | ID: mdl-15113818

ABSTRACT

CONTEXT: Little is known about potential long-term health effects of bioterrorism-related Bacillus anthracis infection. OBJECTIVE: To describe the relationship between anthrax infection and persistent somatic symptoms among adults surviving bioterrorism-related anthrax disease approximately 1 year after illness onset in 2001. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional study of 15 of 16 adult survivors from September through December 2002 using a clinical interview, a medical review-of-system questionnaire, 2 standardized self-administered questionnaires, and a review of available medical records. MAIN OUTCOME MEASURES: Health complaints summarized by the body system affected and by symptom categories; psychological distress measured by the Revised 90-Item Symptom Checklist; and health-related quality-of-life indices by the Medical Outcomes Study 36-Item Short-Form Health Survey (version 2). RESULTS: The anthrax survivors reported symptoms affecting multiple body systems, significantly greater overall psychological distress (P<.001), and significantly reduced health-related quality-of-life indices compared with US referent populations. Eight survivors (53%) had not returned to work since their infection. Comparing disease manifestations, inhalational survivors reported significantly lower overall physical health than cutaneous survivors (mean scores, 30 vs 41; P =.02). Available medical records could not explain the persisting health complaints. CONCLUSION: The anthrax survivors continued to report significant health problems and poor life adjustment 1 year after onset of bioterrorism-related anthrax disease.


Subject(s)
Anthrax , Bioterrorism , Quality of Life , Survivors , Absenteeism , Adult , Anthrax/physiopathology , Anthrax/psychology , Bioterrorism/psychology , Cross-Sectional Studies , Follow-Up Studies , Health Status , Health Status Indicators , Humans , Middle Aged , Respiratory Tract Infections/microbiology , Respiratory Tract Infections/physiopathology , Respiratory Tract Infections/psychology , Skin Diseases, Bacterial/microbiology , Skin Diseases, Bacterial/physiopathology , Skin Diseases, Bacterial/psychology , Stress, Psychological , Survivors/psychology , United States
2.
Clin Infect Dis ; 37(11): 1490-5, 2003 Dec 01.
Article in English | MEDLINE | ID: mdl-14614672

ABSTRACT

Foodborne botulism is caused by potent neurotoxins of Clostridium botulinum. We investigated a large outbreak of foodborne botulism among church supper attendees in Texas. We conducted a cohort study of attendees and investigated the salvage store that sold the implicated foods. We identified 15 cases of botulism (40%) among 38 church supper attendees. Nine patients (60%) had botulinum toxin type A detected in stool specimens. The diagnosis was delayed in 3 cases. Fifteen (63%) of 24 attendees who ate a chili dish developed botulism (relative risk, undefined; P<.001). The chili dish was prepared with "brand X" or "brand Y" frozen chili, "brand Z" canned chili, and hot dogs. An unopened container of brand X chili yielded type A toxin. Brand X chili was purchased at a salvage store where perishable foods were inadequately refrigerated. Our investigation highlights the need to improve clinicians' awareness of botulism. More rigorous and more unannounced inspections may be necessary to detect food mishandling at salvage stores.


Subject(s)
Botulism/epidemiology , Clostridium botulinum , Disease Outbreaks , Food Contamination , Food Microbiology , Adolescent , Adult , Aged , Botulism/physiopathology , Child , Child, Preschool , Cohort Studies , Humans , Male , Middle Aged , Texas/epidemiology
3.
Emerg Infect Dis ; 8(10): 1019-28, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12396909

ABSTRACT

In October 2001, the first inhalational anthrax case in the United States since 1976 was identified in a media company worker in Florida. A national investigation was initiated to identify additional cases and determine possible exposures to Bacillus anthracis. Surveillance was enhanced through health-care facilities, laboratories, and other means to identify cases, which were defined as clinically compatible illness with laboratory-confirmed B. anthracis infection. From October 4 to November 20, 2001, 22 cases of anthrax (11 inhalational, 11 cutaneous) were identified; 5 of the inhalational cases were fatal. Twenty (91%) case-patients were either mail handlers or were exposed to worksites where contaminated mail was processed or received. B. anthracis isolates from four powder-containing envelopes, 17 specimens from patients, and 106 environmental samples were indistinguishable by molecular subtyping. Illness and death occurred not only at targeted worksites, but also along the path of mail and in other settings. Continued vigilance for cases is needed among health-care providers and members of the public health and law enforcement communities.


Subject(s)
Anthrax/epidemiology , Bacillus anthracis/isolation & purification , Bioterrorism/statistics & numerical data , Adult , Aged , Anthrax/drug therapy , Anthrax/mortality , Anthrax/prevention & control , Antibiotic Prophylaxis , Centers for Disease Control and Prevention, U.S. , Disease Outbreaks , Environmental Exposure , Environmental Monitoring , Epidemiological Monitoring , Female , Humans , Infant , Inhalation Exposure , Male , Middle Aged , Occupational Exposure , Postal Service , Powders , Public Health , Respiratory Tract Infections/drug therapy , Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/mortality , Respiratory Tract Infections/prevention & control , Skin Diseases, Bacterial/drug therapy , Skin Diseases, Bacterial/epidemiology , Skin Diseases, Bacterial/microbiology , Skin Diseases, Bacterial/prevention & control , Spores, Bacterial/isolation & purification , United States/epidemiology
4.
Emerg Infect Dis ; 8(10): 1039-43, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12396912

ABSTRACT

On October 15, 2001, a U.S. Senate staff member opened an envelope containing Bacillus anthracis spores. Chemoprophylaxis was promptly initiated and nasal swabs obtained for all persons in the immediate area. An epidemiologic investigation was conducted to define exposure areas and identify persons who should receive prolonged chemoprophylaxis, based on their exposure risk. Persons immediately exposed to B. anthracis spores were interviewed; records were reviewed to identify additional persons in this area. Persons with positive nasal swabs had repeat swabs and serial serologic evaluation to measure antibodies to B. anthracis protective antigen (anti-PA). A total of 625 persons were identified as requiring prolonged chemoprophylaxis; 28 had positive nasal swabs. Repeat nasal swabs were negative at 7 days; none had developed anti-PA antibodies by 42 days after exposure. Early nasal swab testing is a useful epidemiologic tool to assess risk of exposure to aerosolized B. anthracis. Early, wide chemoprophylaxis may have averted an outbreak of anthrax in this population.


Subject(s)
Anthrax/epidemiology , Bacillus anthracis/isolation & purification , Bioterrorism , Public Health/methods , Anthrax/diagnosis , Anthrax/drug therapy , Anthrax/prevention & control , Antibiotic Prophylaxis , Centers for Disease Control and Prevention, U.S./organization & administration , District of Columbia , Environmental Exposure , Equipment Contamination , Humans , Inhalation Exposure , Nasal Mucosa/microbiology , Nasopharynx/microbiology , Risk Factors , United States , Workplace
5.
Emerg Infect Dis ; 8(10): 1066-72, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12396917

ABSTRACT

In October 2001, four cases of inhalational anthrax occurred in workers in a Washington, D.C., mail facility that processed envelopes containing Bacillus anthracis spores. We reviewed the envelopes' paths and obtained exposure histories and nasal swab cultures from postal workers. Environmental sampling was performed. A sample of employees was assessed for antibody concentrations to B. anthracis protective antigen. Case-patients worked on nonoverlapping shifts throughout the facility, suggesting multiple aerosolization events. Environmental sampling showed diffuse contamination of the facility. Potential workplace exposures were similar for the case-patients and the sample of workers. All nasal swab cultures and serum antibody tests were negative. Available tools could not identify subgroups of employees at higher risk for exposure or disease. Prophylaxis was necessary for all employees. To protect postal workers against bioterrorism, measures to reduce the risk of occupational exposure are necessary.


Subject(s)
Anthrax/diagnosis , Anthrax/epidemiology , Bioterrorism , Disease Outbreaks , Inhalation Exposure , Occupational Exposure , Postal Service , Adult , Aged , Anthrax/drug therapy , Anthrax/transmission , Antibiotic Prophylaxis , Bacillus anthracis/isolation & purification , District of Columbia/epidemiology , Environmental Monitoring , Epidemiological Monitoring , Female , Health Surveys , Humans , Male , Middle Aged , Nasopharynx/microbiology , Respiratory Tract Infections/drug therapy , Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/microbiology , Respiratory Tract Infections/transmission , Risk Factors , Serologic Tests , Skin Diseases, Infectious/drug therapy , Skin Diseases, Infectious/epidemiology , Skin Diseases, Infectious/microbiology , Skin Diseases, Infectious/transmission , Time Factors
6.
Emerg Infect Dis ; 8(10): 1138-44, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12396929

ABSTRACT

In October 2001, two envelopes containing Bacillus anthracis spores were processed at the Washington, D.C., Processing and Distribution Center of the U.S. Postal Service; inhalational anthrax developed in four workers at this facility. More than 2,000 workers were advised to complete 60 days of postexposure prophylaxis to prevent inhalational anthrax. Interventions to promote adherence were carried out to support workers, and qualitative information was collected to evaluate our interventions. A quantitative survey was administered to a convenience sample of workers to assess factors influencing adherence. No anthrax infections developed in any workers involved in the interventions or interviews. Of 245 workers, 98 (40%) reported full adherence to prophylaxis, and 45 (18%) had completely discontinued it. Anxiety and experiencing adverse effects to prophylaxis, as well as being <45 years old were risk factors for discontinuing prophylaxis. Interventions, especially frequent visits by public health staff, proved effective in supporting adherence.


Subject(s)
Anthrax/drug therapy , Anthrax/prevention & control , Antibiotic Prophylaxis , Bioterrorism , Inhalation Exposure , Occupational Exposure , Patient Compliance , Postal Service , Adolescent , Adult , Aged , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/therapeutic use , Bacillus anthracis , District of Columbia , Female , Health Surveys , Humans , Male , Middle Aged
7.
Emerg Infect Dis ; 8(10): 1124-32, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12396927

ABSTRACT

We collected data during postexposure antimicrobial prophylaxis campaigns and from a prophylaxis program evaluation 60 days after start of antimicrobial prophylaxis involving persons from six U.S. sites where Bacillus anthracis exposures occurred. Adverse events associated with antimicrobial prophylaxis to prevent anthrax were commonly reported, but hospitalizations and serious adverse events as defined by Food and Drug Administration criteria were rare. Overall adherence during 60 days of antimicrobial prophylaxis was poor (44%), ranging from 21% of persons exposed in the Morgan postal facility in New York City to 64% of persons exposed at the Brentwood postal facility in Washington, D.C. Adherence was highest among participants in an investigational new drug protocol to receive additional antibiotics with or without anthrax vaccine--a likely surrogate for anthrax risk perception. Adherence of <60 days was not consistently associated with adverse events.


Subject(s)
Anthrax/drug therapy , Anthrax/prevention & control , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/therapeutic use , Antibiotic Prophylaxis , Patient Compliance , Adolescent , Adult , Aged , Aged, 80 and over , Amoxicillin/administration & dosage , Amoxicillin/adverse effects , Amoxicillin/therapeutic use , Anti-Bacterial Agents/administration & dosage , Anti-Infective Agents/administration & dosage , Anti-Infective Agents/adverse effects , Anti-Infective Agents/therapeutic use , Bioterrorism , Ciprofloxacin/administration & dosage , Ciprofloxacin/adverse effects , Ciprofloxacin/therapeutic use , District of Columbia , Doxycycline/administration & dosage , Doxycycline/adverse effects , Doxycycline/therapeutic use , Drug Administration Schedule , Ethnicity , Female , Humans , Male , Middle Aged , New York City , Penicillins/administration & dosage , Penicillins/adverse effects , Penicillins/therapeutic use , Risk Factors , Treatment Refusal
8.
J Am Pharm Assoc (Wash) ; 42(5 Suppl 1): S50-1, 2002.
Article in English | MEDLINE | ID: mdl-12296554

ABSTRACT

Following the terrorist attacks of September 11, 2001, the federal response plan was activated immediately, with most efforts focused on helping recovery workers at Ground Zero in New York City. Comprehensive pharmacy services were critical in protecting the health of those potentially exposed to anthrax at U.S. Postal Service facilities and the U.S. Capitol. Responding to anthrax attacks taught many valuable lessons to emergency workers on how to manage a bioterrorist attack. Because of its central place in the life of many American communities, pharmacy is a natural and important ally of public health.


Subject(s)
Bioterrorism , Disaster Planning , Pharmaceutical Services/organization & administration , United States Public Health Service , Anthrax Vaccines/therapeutic use , Humans , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...